HCIT & Life Sciences

The intersection of trends in HCIT and Life Sciences technology is a core thesis that we continue to applaud. These intersecting technologies not only allow providers to understand patients better, but can also deliver customized experiences in addition to elevating health care engagement.

 Transactions

Led by Fred, Team AGC did an amazing job from project launch to close date. Navigating through this maze of rather complex steps, especially during COVID, was somewhat intimidating but AGC guided and supported us through the whole process. I just can't see how we would have been able to plow through this critical work without the sound advice of M&A advisors of that caliber. Fred was able to translate what made STACS DNA a leader in its field into a compelling and concrete story for potential investors and conducted this exercise where we ultimately moved forward with a best-in-class partner. AGC came highly recommended, and I now see why. I would recommend them without reservation. It was a pleasure working with Fred, Daniel, Zack and Patrick and praise all the great work they did for us.

Jocelyn Tremblay, President and COO, STACS DNA

"For many closely-held business owners, the sale of their company or a large capital round is one of the biggest decisions we will ever make. Choosing the right advisor to assist in this process is critical to achieving the best value, terms and overall outcome. When I think about my experience with AGC, I can say selecting them without question was the best decision I made in the entire process. They became part of my team and worked harder than anyone I had ever seen. While in the end we signed the perfect deal, the process alone with AGC has been one of the most valuable investments of time for my company and me personally."

Weston Lunsford, CEO, Dental Intelligence

Get in touch and experience the AGC difference